Lysins - a new armamentarium for the treatment of bone and joint infections?
作者信息
Sendi Parham, Ferry Tristan
机构信息
Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
JBJI Editor-in-chief.
出版信息
J Bone Jt Infect. 2022 Sep 6;7(5):187-189. doi: 10.5194/jbji-7-187-2022. eCollection 2022.
Abstract
摘要
相似文献
1
Lysins - a new armamentarium for the treatment of bone and joint infections?溶素——治疗骨与关节感染的新型武器库？
J Bone Jt Infect. 2022 Sep 6;7(5):187-189. doi: 10.5194/jbji-7-187-2022. eCollection 2022.
2
Novel method to control pathogenic bacteria on human mucous membranes.控制人体粘膜上病原菌的新方法。
Ann N Y Acad Sci. 2003 Apr;987:207-14. doi: 10.1111/j.1749-6632.2003.tb06050.x.
3
Gram-Negative Bacterial Lysins.革兰氏阴性菌溶素
Antibiotics (Basel). 2020 Feb 11;9(2):74. doi: 10.3390/antibiotics9020074.
4
A Novel Podophage Encodes a Unique Lysin with Unusual Modular Design.一种新型噬菌体编码具有独特模块化设计的独特溶菌酶。
mSphere. 2017 Mar 22;2(2). doi: 10.1128/mSphere.00040-17. eCollection 2017 Mar-Apr.
5
Isolation of Phage Lysins That Effectively Kill Pseudomonas aeruginosa in Mouse Models of Lung and Skin Infection.噬菌体溶菌素在肺部和皮肤感染的小鼠模型中有效杀灭铜绿假单胞菌的分离。
Antimicrob Agents Chemother. 2019 Jun 24;63(7). doi: 10.1128/AAC.00024-19. Print 2019 Jul.
6
Bacteriophages and Lysins in Biofilm Control.噬菌体和生物膜控制中的溶菌素
Virol Sin. 2020 Apr;35(2):125-133. doi: 10.1007/s12250-019-00192-3. Epub 2020 Mar 3.
7
Engineered Lysins With Customized Lytic Activities Against Enterococci and Staphylococci.具有针对肠球菌和葡萄球菌定制裂解活性的工程溶素
Front Microbiol. 2020 Nov 25;11:574739. doi: 10.3389/fmicb.2020.574739. eCollection 2020.
8
Lysins: the arrival of pathogen-directed anti-infectives.溶菌素：靶向病原体的抗感染药物的问世。
J Med Microbiol. 2013 Oct;62(Pt 10):1506-1516. doi: 10.1099/jmm.0.061028-0. Epub 2013 Jun 27.
9
Sequence-Function Relationships in Phage-Encoded Bacterial Cell Wall Lytic Enzymes and Their Implications for Phage-Derived Product Design.噬菌体编码的细菌细胞壁溶酶及其序列-功能关系在噬菌体衍生产品设计中的意义。
J Virol. 2021 Jun 24;95(14):e0032121. doi: 10.1128/JVI.00321-21.
10
Enhancement of the direct antimicrobial activity of Lysep3 against Escherichia coli by inserting cationic peptides into its C terminus.通过在Lysep3的C末端插入阳离子肽来增强其对大肠杆菌的直接抗菌活性。
Antonie Van Leeuwenhoek. 2017 Mar;110(3):347-355. doi: 10.1007/s10482-016-0806-2. Epub 2016 Dec 10.
引用本文的文献
1
A Longer Duration of Intravenous Antibiotic Treatment for Patients with Early Periprosthetic Joint Infections Is Not Associated with a Lower Failure Rate.早期人工关节周围感染患者延长静脉抗生素治疗时间与较低的失败率无关。
Antibiotics (Basel). 2025 Jan 13;14(1):79. doi: 10.3390/antibiotics14010079.
2
Exploring the potential of naturally occurring antimicrobials for managing orthopedic-device-related infections.探索天然存在的抗菌剂在处理骨科器械相关感染方面的潜力。
J Bone Jt Infect. 2024 Oct 31;9(5):249-260. doi: 10.5194/jbji-9-249-2024. eCollection 2024.
本文引用的文献
1
Locally delivered antistaphylococcal lysin exebacase or CF-296 is active in methicillin-resistant implant-associated osteomyelitis.局部递送的抗葡萄球菌溶素埃克西巴酶或CF-296在耐甲氧西林的植入物相关骨髓炎中具有活性。
J Bone Jt Infect. 2022 Jul 27;7(4):169-175. doi: 10.5194/jbji-7-169-2022. eCollection 2022.
2
Successful Use of Salvage Bacteriophage Therapy for a Recalcitrant MRSA Knee and Hip Prosthetic Joint Infection.挽救性噬菌体疗法成功用于治疗耐甲氧西林金黄色葡萄球菌引起的顽固性膝关节和髋关节假体关节感染。
Pharmaceuticals (Basel). 2022 Jan 31;15(2):177. doi: 10.3390/ph15020177.
3
Case Report: Arthroscopic "Debridement Antibiotics and Implant Retention" With Local Injection of Personalized Phage Therapy to Salvage a Relapsing Prosthetic Knee Infection.病例报告：关节镜下“清创、抗生素治疗及植入物保留”联合局部注射个性化噬菌体疗法挽救复发性人工膝关节感染
Front Med (Lausanne). 2021 May 5;8:569159. doi: 10.3389/fmed.2021.569159. eCollection 2021.
4
Activity of Lysin CF-296 Alone and in Addition to Daptomycin in a Rat Model of Experimental Methicillin-Resistant Staphylococcus aureus Osteomyelitis.溶菌酶CF-296单独及联合达托霉素在耐甲氧西林金黄色葡萄球菌实验性骨髓炎大鼠模型中的活性
Antimicrob Agents Chemother. 2021 May 18;65(6). doi: 10.1128/AAC.00117-21.
5
Phage Therapy as Adjuvant to Conservative Surgery and Antibiotics to Salvage Patients With Relapsing Prosthetic Knee Infection.噬菌体疗法作为保守手术和抗生素的辅助手段用于挽救复发性人工膝关节感染患者。
Front Med (Lausanne). 2020 Nov 16;7:570572. doi: 10.3389/fmed.2020.570572. eCollection 2020.
6
The Safety and Efficacy of Phage Therapy for Bone and Joint Infections: A Systematic Review.噬菌体疗法治疗骨与关节感染的安全性和有效性：一项系统评价
Antibiotics (Basel). 2020 Nov 10;9(11):795. doi: 10.3390/antibiotics9110795.
7
Phage Therapy for Limb-threatening Prosthetic Knee Klebsiella pneumoniae Infection: Case Report and In Vitro Characterization of Anti-biofilm Activity.噬菌体疗法治疗危及肢体的人工膝关节耐甲氧西林肺炎克雷伯菌感染：病例报告及抗生物膜活性的体外特征。
Clin Infect Dis. 2021 Jul 1;73(1):e144-e151. doi: 10.1093/cid/ciaa705.
8
Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis.治疗金黄色葡萄球菌血流感染和心内膜炎的药物。
J Clin Invest. 2020 Jul 1;130(7):3750-3760. doi: 10.1172/JCI136577.
9
The Value of Ortho-ID Teams in Treating Bone and Joint Infections.骨科-ID团队在治疗骨与关节感染中的价值。
J Bone Jt Infect. 2019 Nov 20;4(6):295-299. doi: 10.7150/jbji.41663. eCollection 2019.
10
Exebacase in Addition to Daptomycin Is More Active than Daptomycin or Exebacase Alone in Methicillin-Resistant Staphylococcus aureus Osteomyelitis in Rats.依替米星联合达托霉素较达托霉素或依替米星单药对耐甲氧西林金黄色葡萄球菌感染大鼠骨髓炎更有效。
Antimicrob Agents Chemother. 2019 Sep 23;63(10). doi: 10.1128/AAC.01235-19. Print 2019 Oct.
Zotero 插件